IMW 2019 | An update on the genomic landscape of MM

Brian Walker

Brian Walker, PhD, the University of Arkansas for Medical Sciences, Little Rock, AR, discusses the important aspects of myeloma genomics and how exome sequencing in large patient cohorts has revealed the prognostic significance of biallelic inactivation of TP53 and other mutations. This interview was held at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video